does tirzepatide or semaglutide have less side effects Why Doesn't Work for Some People: Causes and Solutions pros and cons of semaglutide

GLP-1 receptor agonists are generally safe for patients with hypertension, but blood pressure should be monitored regularly as part of routine care

Chest discomfort : Ranging from mild tightness to more significant pain, particularly during physical activity or at rest if heart rate is substantially elevated

An estimated 50-75% of users stop taking these drugs within a year

Ontogenetic profile of the expression of thyroid hormone receptors in rat and human corpora cavernosa of the penis

"Some can maintain on a lower dose, while others require ongoing therapy at their current dose." If you're like me and squeamish about the prospect of weekly injections indefinitely, take note that oral GLP-1s are now on the market: the Food and Drug Administration (FDA) approved oral Wegovy in December 2025 and Foundayo (orforglipron) in April 2026